This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT05243797
Brief Title: Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation (MajesTEC-4)

First Submitted : January 27, 2022
First Submitted that Met QC Criteria : February 7, 2022
First Posted : February 17, 2022

Last Update Submitted that Met QC Criteria : July 4, 2023
Last Update Posted : July 6, 2023